−£1.11m
vs Mar 2024Active09318613Private limited companyChester
LINICAL UK LIMITED
Significant control: Linical Co., Ltd (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Linical UK Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Linical UK Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
LINICAL UK LIMITED is an active private limited company (company number 09318613) incorporated on 19 November 2014, registered in Chester. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of −£1.11m and cash of £110k, with 13 employees on average. Net assets fell 8% on the prior period (−£1.02m).
Peer position · net assets
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Linical Co., Ltd
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Accelovance Inc.
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 19 November 201411 yrs ago
- Next accounts due
- 31 December 2026in 66 days
- Confirmation statement due
- 3 December 2026in 38 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£110k
−44%vs Mar 2024Not reported
13
+86%vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£1.11m | £110k | £1.68m | — | — | — | 13 |
| 31 March 2024 | −£1.02m | £196k | £1.39m | — | — | — | 7 |
Cash per employee£8,459Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-1,105,569 at 31 March 2025
- Cash at bank of £50,000 or moreCash £109,965
- Incorporated five or more years agoIncorporated 19 November 2014
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 66 days
- Confirmation statement duein 38 days
- Accounts period endNet liabilities £1.11m · small accounts
- Accounts period endNet liabilities £1.02m · small accounts
- Incorporated
08
Similar companies in Liverpool
- NANO BIOSOLS LTDLiverpool · inc. Oct 2014
- DP AND MARINE ASSURANCE (UK) LIMITEDLiverpool · inc. May 2015
- S.B. PHARMA GROUP LIMITEDLiverpool · inc. Jun 2015
- EXTENTUS PHARMA LTDLiverpool · inc. Mar 2014
- OXFORD BIOANALYTICAL TESTING LIMITEDLiverpool · inc. Sept 2013
- CERNERETEC LTDLiverpool · inc. Jan 2016
All companies incorporated on 19 November 2014 · in Nov 2014.
09
Reminders for LINICAL UK LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.